Regulatory updates
Found daily at official sources (the Federal Register, eCFR, FDA, FTC, USP, and California’s OEHHA), summarised from the source text only and checked against it before it appears here. Every item links to the primary document; most carry a full article on what it means for a supplement brand.
Subscribe (RSS)Get these by email (free)Requirements library18 published
According to the FDA, Miracle Power of King Kong Honey, promoted for sexual enhancement and sold online and possibly in stores, contains hidden tadalafil. The ingredient can interact with nitrates in some prescription drugs and may lower blood pressure to dangerous levels, especially for people with diabetes, high blood pressure, high cholesterol, or heart disease.
What to do
No action needed.
FDA is amending food additive regulations to allow vitamin D2 inactive bakers yeast as a source of vitamin D2 in specific food categories, responding to a petition from Lallemand Inc. The permitted uses and maximum levels mirror those already authorized for vitamin D2 mushroom powder, meaning no increase in overall vitamin D dietary exposure is expected. Affected product categories include breakfast cereals, plant-based beverages and yogurt alternatives, fruit juices, soups, and yeast-leavened baked goods.
What to do
Brands should review the listed food categories and maximum vitamin D2 levels if they intend to formulate with vitamin D2 inactive bakers yeast.
The provided text discusses loyalty discounts and network effects in the context of FTC v. Surescripts, not Amway. No regulatory item for US dietary supplement brand owners is present.
What to do
No action needed.
The FDA issued the 2026 Food Code, a model code for retail food safety. The text does not mention dietary supplement brands or products. It addresses restaurants, retail food stores, and food service operations, covering topics like allergen cross-contact, specialty mushroom hazards, and employee illness policies.
What to do
No action needed.
The FDA advises consumers not to purchase or use ZUBB Dietary Supplement, a product promoted for weight loss. According to the FDA notice, it was identified during an examination of international mail shipments. FDA laboratory analysis confirmed the product contains sildenafil, the active ingredient in Viagra, not listed on the label. Sildenafil may dangerously lower blood pressure when combined with nitrates, especially for those with diabetes, high blood pressure, high cholesterol, or heart disease.
What to do
No action needed.
An FDA webinar on 21 CFR Part 111 product specifications offered compliance insights for dietary supplement manufacturers and document reviewers, according to industry press.
What to do
No action needed.
The Council for Responsible Nutrition welcomed FDA's proposed GRAS transparency rule. CRN supports enhanced accountability for self-GRAS reviews and FDA visibility into ingredients, but warns against eliminating self-GRAS, which could stifle innovation. It proposes a GRAS ingredient registry and urges national uniformity to prevent conflicting state requirements.
What to do
Review your GRAS determinations and prepare to engage with the proposed rule through industry associations like CRN.
The source title indicates FDA proposed mandatory GRAS notifications, but the provided article body covers only ashwagandha health topics and does not describe any regulatory change, detail, or industry comment.
What to do
No action needed.
An industry press article reports experts doubt FDA has the manpower to handle mandatory GRAS notifications if the proposed rule is finalized. This could affect how dietary supplement ingredient safety reviews are managed.
What to do
No action needed.
Revival Animal Health is recalling its Breeder’s Edge® and Shelter’s Choice® Feline Milk Replacers because they contain low levels of potassium, copper, folic acid, choline, and/or pyridoxine (vitamin B6). This is a pet food recall, not a human dietary supplement action.
What to do
No action needed.
The FDA announced a request for information seeking public input on advancing botanical drug products, according to a press announcement.
What to do
No action needed.
SUPPLX.com is voluntarily recalling 'Business Pill' and 'Branch Manager for Men' dietary supplements marketed for male sexual enhancement. FDA laboratory analysis found the products contain undeclared yohimbine.
What to do
No action needed.
OEHHA announced a November 17, 2026 meeting where the Carcinogen Identification Committee will review whether ethoprop should remain on California's Proposition 65 list of cancer-causing chemicals, according to an OEHHA notice. A 45-day public comment period on a hazard identification document ends October 19, 2026. No submissions were received during a prior information request.
What to do
No action needed.
The FDA opened a public docket (FDA-2026-N-9550) to request comments by November 3, 2026, on advancing development of botanical drug products. The agency seeks stakeholder perspectives on challenges and potential solutions in gathering information required by the FD&C Act, according to the Federal Register.
What to do
No action needed.
The FDA announced a public meeting on March 3, 2026, regarding Dietary Supplement Innovation and the Scope of Dietary Ingredients. According to the FDA's HFP Constituent Updates, this meeting concerns dietary supplement innovation and the scope of dietary ingredients.
What to do
No action needed.
The FDA is proposing a rule to make GRAS notices mandatory, with some exceptions. It would require persons introducing a human or animal food substance under the GRAS provision to notify the FDA of their safety conclusion. The rule, if finalized, aims to increase transparency and help the FDA identify potentially unsafe substances. Comments on the proposal are due by December 9, 2026.
What to do
Submit comments on the proposed rule by December 9, 2026.
California OEHHA has released draft Prop 65 rule changes open for public comment. One change narrows the 'naturally occurring' exemption: a chemical extracted or concentrated from a plant can now count as human-caused even if it wasn't chemically altered — relevant if you sell botanical extracts. Other changes touch internet-purchase warnings and add QR codes as an approved warning method.
What to do
If you sell botanical-extract products or ship into California, review whether the naturally-occurring and internet-purchase/QR-code warning changes affect your labeling, and consider submitting a comment before the rulemaking is finalized.
FDA approved wider use of spirulina extract as a color additive in foods generally, including coating formulations applied to dietary supplement tablets and capsules, and tightened the allowed limits for lead, arsenic, mercury and (new) cadmium in the ingredient.
What to do
If your tablets or capsules use a spirulina-based coloring in the coating, confirm with your contract manufacturer or ingredient supplier that the spirulina extract they use meets the new, lower heavy-metal limits.
Compliant Always customers see these filtered to their own product types inside the portal, with an unread count. This page is the same list, unfiltered.
